Anteris Technologies (AVR) has launched a US$20 million (A$27.5 million) placement to US-based investment management firm Perceptive AdvisorsThe healthcare stock penned an agreement with Perceptive Life Sciences Master Fund for the placement, which will see Perceptive become Anteris’ largest shareholderAnteris will issue 1.84 million shares at $15 each, representing a 20 per cent discount to its last closing price on February 28The funds will be used to develop its 3D single-piece aortic valve replacement, DurAVR, to treat patients with aortic stenosis in upcoming clinical trialsAnteris shares are up 3.11 per cent to trade at $19.25
Anteris was up 3.11 per cent to trade at $19.25 at 1:15 pm AEDT.
Anteris Technologies (ASX:AVR) gets US$20m boost for DurAVR development,
https://themarketherald.com.au/anteris-technologies-asxavr-gets-us20m-boost-for-duravr-development-2022-03-02/?jwsource=cl
- Forums
- ASX - By Stock
- AVR
- Wayne interview with The Market Herald
Wayne interview with The Market Herald
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$21.50 |
Change
-0.200(0.92%) |
Mkt cap ! $413.0M |
Open | High | Low | Value | Volume |
$21.46 | $21.50 | $21.46 | $7.798K | 363 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 145 | $21.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.50 | 120 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 145 | 21.280 |
2 | 448 | 21.160 |
1 | 150 | 21.150 |
1 | 223 | 21.120 |
1 | 1436 | 21.100 |
Price($) | Vol. | No. |
---|---|---|
21.500 | 120 | 3 |
21.510 | 21 | 1 |
21.520 | 1270 | 2 |
21.600 | 4700 | 1 |
21.700 | 776 | 1 |
Last trade - 10.04am 02/05/2024 (20 minute delay) ? |
|
|||||
Last
$21.50 |
  |
Change
-0.200 ( 0.51 %) |
|||
Open | High | Low | Volume | ||
$21.49 | $21.50 | $21.49 | 100 | ||
Last updated 10.47am 02/05/2024 ? |
Featured News
AVR (ASX) Chart |
The Watchlist
BPH
BPH ENERGY LTD
David Breeze, MD & Executive Chairman
David Breeze
MD & Executive Chairman
SPONSORED BY The Market Online